Registered entities
Rigel Pharmaceuticals Inc
Reg. No. 1034842United States
Rigel Pharmaceuticals, Inc
Reg. No. 94‑3248524United States
Rigel Pharmaceuticals Inc.
Reg. No. 943248524United States
Rigel Pharmaceuticals, Inc.
Reg. No. 39.995.548/0001-54Brazil
Social engagement
Social engagement: 13.3K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Private equity | 2 | 25% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 2 | 25% |
Recent activity
18 Jun 2026
Partnership
Rigel Pharmaceuticals Inc.
11 Jun 2026
Event
REZLIDHIA (olutasidenib) posters at EHA_Hematology 2026 Congress
2 Jun 2026
Event
Jefferies Global Healthcare Conference